XML 20 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities:    
Net loss $ (262,831) $ (111,303)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization expense 4,580 1,404
Share-based compensation expenses 36,037 13,074
Acquired in-process research and development 10,000  
Non-cash interest expense 4,115 2,232
Deferred income tax benefits (8,413) (4,059)
Other non-cash income (2,336) (3)
Changes in operating assets and liabilities:    
Accounts receivable (3,743)  
Unbilled receivable 3,605  
Inventories 4,608  
Prepaid expenses and other current assets (27,669) (5,036)
Other non-current assets (3,694) (139)
Accounts payable 10,308 13,242
Accrued expenses and other payables 25,439 130
Tax payable (8,005) 2,302
Deferred revenue (3,442)  
Other long-term liabilities (197) 559
Net cash used in operating activities (221,638) (87,597)
Investing activities:    
Purchases of property and equipment (20,309) (8,881)
Payment for the acquisition of land use right   (12,124)
Purchases of investments (1,198,922) (27,646)
Proceeds from sale or maturity of available-for-sale securities 869,011 161,900
Purchase of in-process research and development (10,000)  
Net cash (used in) provided by investing activities (360,220) 113,249
Financing activities:    
Proceeds from public offering, net of underwriter discount 758,001  
Payment of public offering cost (414)  
Proceeds from long-term loan 42,315  
Proceeds from short-term loan   2,470
Repayment of short-term loan   (2,470)
Capital contribution from noncontrolling interest   14,527
Proceeds from shareholder loan   132,757
Proceeds from option exercises 10,582 316
Net cash provided by financing activities 810,484 147,600
Effect of foreign exchange rate changes, net 1,783 240
Net increase in cash, cash equivalents, and restricted cash 230,409 173,492
Cash, cash equivalents, and restricted cash at beginning of period 239,602 87,514
Cash, cash equivalents, and restricted cash at end of period 470,011 261,006
Supplemental cash flow disclosures:    
Cash and cash equivalents 438,420 261,006
Restricted Cash 31,591  
Income taxes paid 11,842 746
Interest expense paid 667 618
Non-cash activities:    
Acquisitions of equipment included in accounts payable 8,006 $ 1,373
Changes in operating assets and liabilities adjusted through accumulated deficit $ 2,291